Vycor Medical (VYCO) Cash from Operations Growth (1y) (2011 - 2026)
Powered by 
Analysis
Vycor Medical (VYCO) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -12.60% |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -110.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -110.39% |
| Mar 31, 2026 | 469.47% |
| Dec 31, 2025 | 202.48% |
| Sep 30, 2025 | -791.76% |
| Jun 30, 2025 | -45.80% |
| Mar 31, 2025 | -1,526.02% |
| Dec 31, 2024 | -795.01% |
| Sep 30, 2024 | 170.44% |
| Jun 30, 2024 | 507.41% |
| Mar 31, 2024 | -92.34% |
| Dec 31, 2023 | 116.51% |
| Sep 30, 2023 | 80.63% |
| Jun 30, 2023 | 150.34% |
| Mar 31, 2023 | 131.25% |
| Dec 31, 2022 | -206.04% |
| Sep 30, 2022 | -23.00% |
| Jun 30, 2022 | -132.54% |
| Mar 31, 2022 | -130.62% |
| Dec 31, 2021 | 630.49% |
| Sep 30, 2021 | 61.89% |